VeriMomdihydroartemisinic acid est-il sûr pendant la grossesse ?
No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
Related ingredients
Frequently asked questions
- dihydroartemisinic acid est-il sûr pendant la grossesse ?
- No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- dihydroartemisinic acid est-il sûr pendant l'allaitement ?
- Same evidence base as pregnancy: no regulatory or peer‑reviewed data indicating reproductive or lactation-specific hazard for DHAA. With no data of transfer into milk for DHAA, exposure scoring follows the adult topical route (low but measurable dermal absorption, e=1). No breastfeeding‑specific studies were found. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- dihydroartemisinic acid est-il sûr pour la peau de bébé ?
- No infant‑specific toxicity or developmental dermatotoxicity data were found. Following your rules, because adult topical exposure is scored as measurable (e=1) and the compound is moderately lipophilic (logP ~3.7, MW 236) infant exposure is increased by +1 for immature barrier/higher SA:BW, giving e=2. Hazard and mechanism remain 0 in absence of reproductive/ED/teratogenic evidence. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- Comment VeriMom évalue-t-il dihydroartemisinic acid ?
- VeriMom évalue dihydroartemisinic acid à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à dihydroartemisinic acid pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à dihydroartemisinic acid basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.